SE8000545L - Mellanprodukter for prostaglandinanaloger - Google Patents

Mellanprodukter for prostaglandinanaloger

Info

Publication number
SE8000545L
SE8000545L SE8000545A SE8000545A SE8000545L SE 8000545 L SE8000545 L SE 8000545L SE 8000545 A SE8000545 A SE 8000545A SE 8000545 A SE8000545 A SE 8000545A SE 8000545 L SE8000545 L SE 8000545L
Authority
SE
Sweden
Prior art keywords
group
image
hydroxy
alkyl
formula
Prior art date
Application number
SE8000545A
Other languages
English (en)
Other versions
SE452157B (sv
Inventor
H Wakatsuka
M Kawamure
T Okada
M Hayashi
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP655579A external-priority patent/JPS55100377A/ja
Priority claimed from JP655679A external-priority patent/JPS55100378A/ja
Priority claimed from JP655779A external-priority patent/JPS55100379A/ja
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of SE8000545L publication Critical patent/SE8000545L/sv
Publication of SE452157B publication Critical patent/SE452157B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8000545A 1979-01-25 1980-01-23 Mellanprodukter for framstellning av trans- delta ?722-prostaglandin-e?711 -analoger och forfarande for framstellning av dessa SE452157B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP655579A JPS55100377A (en) 1979-01-25 1979-01-25 Intermediate for prostaglandim analog and its preparation
JP655679A JPS55100378A (en) 1979-01-25 1979-01-25 Intermediate for prostaglandin analog and its preparation
JP655779A JPS55100379A (en) 1979-01-25 1979-01-25 Preparation of prostaglandin analog and its intermediate

Publications (2)

Publication Number Publication Date
SE8000545L true SE8000545L (sv) 1980-07-26
SE452157B SE452157B (sv) 1987-11-16

Family

ID=27277218

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8000545A SE452157B (sv) 1979-01-25 1980-01-23 Mellanprodukter for framstellning av trans- delta ?722-prostaglandin-e?711 -analoger och forfarande for framstellning av dessa

Country Status (9)

Country Link
CA (1) CA1154441A (sv)
CH (1) CH644360A5 (sv)
DK (1) DK165111C (sv)
FR (1) FR2447374A1 (sv)
GB (1) GB2045745B (sv)
HU (1) HU183068B (sv)
IT (1) IT1149877B (sv)
NL (1) NL8000428A (sv)
SE (1) SE452157B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540427A (en) * 1972-12-29 1979-02-14 Ono Pharmaceutical Co Prostaglandin analogues
US3931296A (en) * 1972-12-29 1976-01-06 Masaki Hayashi Trans-Δ2 -prostaglandins

Also Published As

Publication number Publication date
FR2447374A1 (fr) 1980-08-22
HU183068B (en) 1984-04-28
CA1154441A (en) 1983-09-27
DK165111C (da) 1993-03-01
NL8000428A (nl) 1980-07-29
DK27780A (da) 1980-07-26
FR2447374B1 (sv) 1981-12-11
IT8019399A0 (it) 1980-01-23
IT1149877B (it) 1986-12-10
SE452157B (sv) 1987-11-16
GB2045745A (en) 1980-11-05
DK165111B (da) 1992-10-12
CH644360A5 (fr) 1984-07-31
GB2045745B (en) 1983-08-17

Similar Documents

Publication Publication Date Title
US4111995A (en) 2-Decarboxy-2-hydroxymethyl-ω-phenoxy-PGD analogs
US4096179A (en) 13,14-Dihydro-16-phenoxy prostaglandin F1α analogs
US4097508A (en) Cis-4,5-didehydro-13,14 dihydro-9, dioxy PGF compounds
US4137403A (en) 9-Deoxy-9-methylene-PGF2 cycloamides
SE8000545L (sv) Mellanprodukter for prostaglandinanaloger
US4057574A (en) 2,2-Difluoro-16-phenoxy-13,14-dihydro-PGA2 analogs
US4148828A (en) 2-Decarboxy-2-alkylcarbonyl-3,7-inter-m-phenylene-3-oxa-4,5,6-trinor-PGA or PGB compounds
DK122085A (da) Mellemprodukter til fremstilling af prostaglandinanaloge
US4125734A (en) 5-Oxa-13,14-didehydro-11-deoxy-PGE1 compounds
US4152523A (en) 11-Deoxy-17-phenyl-13,14-dihydro-PGE1 compounds
GB1508170A (en) Substituted cyclopentane compounds useful as intermediates in the synthesis of prostaglandin analogues
ES547691A0 (es) Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos
US4257981A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-PG2 compounds
US4269995A (en) 19,20-Didehydro-13,14-dihydro-PG2 compounds
US4264524A (en) 19,20-Didehydro-PG1 amides
US4283350A (en) 19,20-Didehydro-PG2 amides
US4257983A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-PG1 compounds
US4276434A (en) 19,20-Didehydro-13,14-dihydro-PG1, sulfonyl amides
US4264523A (en) 19,20-Didehydro-13,14-dihydro-PG1 amides
ZA807538B (en) Silyl-benzimidazole-2-carbamic acid esters, their preparation and their use as fungicides
US4257982A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-13,14-dihydro-PG2 compounds
US4257980A (en) 2-Decarboxy-2-aminomethyl-19,20-didehydro-13,14-dihydro-PG1 compounds
US4336372A (en) 2-Decarboxy-2-tetrazolyl-PG2 compounds
US4278812A (en) 19,20-Didehydro-PG2 sulfonyl amides
US4056554A (en) 2,2-Difluoro-16-phenoxy-13,14-dihydro-PGF1, analogs

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8000545-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8000545-7

Format of ref document f/p: F